NAKA
Nakamoto Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$8.13
−2.17%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 39.4M | 1.8M | 2.7M | 3.8M | 3.8M |
| Cost of Revenue | 33.8M | 11.1M | 3.6M | 226.2K | 152.4K |
| Gross Profit | 5.6M | (9.3M) | (842.6K) | 3.5M | 3.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | 377.7K | 2.5K | — |
| SG&A Expense | 31.5M | 11.8M | 1.9M | 5.1M | 6.3M |
| General & Admin Expense | 31.5M | 11.8M | 1.9M | 5.1M | 6.3M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 443.1M | 176.1M | 219.4K | 105.6K | 53.4K |
| Total Operating Expenses | 474.6M | 187.9M | 2.5M | 5.2M | 6.3M |
| Cost and Expenses | 508.3M | 199.0M | 6.1M | 5.4M | 6.5M |
| Operating Income (EBIT) | (469.0M) | (197.1M) | (3.3M) | (1.6M) | (2.7M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 15.3M | 7.1M | 393.4K | 55.8K | — |
| Net Interest Income | (15.3M) | (7.1M) | (393.4K) | (55.8K) | — |
| Other Non-Op Income/Expense | 28.8M | 144.9M | (270.9K) | 2.8K | 152.8K |
| Non-Operating Income (excl Interest) | (44.1M) | (152.0M) | (122.6K) | (58.6K) | (152.8K) |
| EBT (Pre-Tax Income) | (440.2M) | (52.2M) | (3.6M) | (1.6M) | (2.5M) |
| Income Tax Expense | (21.4M) | — | — | — | — |
| Bottom Line | |||||
| Net Income | (420.6M) | (52.2M) | (3.6M) | (1.6M) | (2.5M) |
| Earnings from Cont. Ops | (418.8M) | (52.2M) | (3.6M) | (1.6M) | (2.5M) |
| Earnings from Discont. Ops | (1.8M) | — | — | — | — |
| Bottom Line Net Income | (420.6M) | (52.2M) | (3.6M) | (1.6M) | (2.5M) |
| Per Share | |||||
| Basic EPS | ($35.85) | ($10.40) | ($0.67) | ($0.27) | ($0.43) |
| Diluted EPS | ($35.85) | ($10.40) | ($0.67) | ($0.27) | ($0.43) |
| Revenue Per Share | $1.97 | $0.16 | $0.50 | $0.64 | $0.64 |
| Shares | |||||
| Basic Shares Outstanding | 20.0M | 11.4M | 5.4M | 5.9M | 5.9M |
| Diluted Shares Outstanding | 20.0M | 11.4M | 5.4M | 5.9M | 5.9M |
| Profitability Metrics | |||||
| EBITDA | (420.6M) | (44.9M) | (3.0M) | (1.4M) | (2.4M) |
| D&A | 4.3M | 242.0K | 220.3K | 203.2K | 122.0K |
| EBIT | (424.9M) | (45.2M) | (3.2M) | (1.6M) | (2.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026